Search clinical trials for: Doxorubicin

Conditions: Triple Negative Breast Cancer; Hormone Receptor Positive (HR+), HER2-negative Breast Cancer; Biopsy-proven, Positive Lymph Node(s)

Conditions: DLBCL; Untreated; MYC Gene Rearrangement

Conditions: Sarcoma; Osteoid Sarcoma; Ewing Sarcoma

Conditions: Epithelial Ovarian Cancer

Conditions: Prostate Cancer

Conditions: PTCL, NOS; AITL; ALK- ALCL; Phase III-IV ALK+ ALCL; EATL

Conditions: Rhabdomyosarcoma

Conditions: Osteosarcoma

Conditions: Stage II Bladder Cancer AJCC v8; Stage IIIA Bladder Cancer AJCC v8

Conditions: Breast Cancer; Breast Neoplasms

Conditions: Gastric Cancer

Conditions: Diffuse Large B-Cell Lymphoma

Conditions: Sarcoma, Soft Tissue

Conditions: Osteosarcoma; Survival; Chemotherapy Effect; Toxicity, Drug

Conditions: Ovarian Cancer

Conditions: DLBCL; Diffuse Large B Cell Lymphoma

Conditions: Clinical Stage IV Gastric Cancer AJCC v8; Clinical Stage IVA Gastric Cancer AJCC v8; Clinical Stage IVB Gastric Cancer AJCC v8; Malignant Uterine Neoplasm; Metastatic Colorectal Carcinoma; Metastatic Gastric Carcinoma; Metastatic Malignant Neoplasm in the Peritoneum; Metastatic Ovarian Carcinoma; Pathologic Stage IV Gastric Cancer AJCC v8; Peritoneal Carcinomatosis; Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8; Stage IV Colorectal Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Uterine Corpus Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVA Ovarian Cancer AJCC v8; Stage IVA Uterine Corpus Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVB Ovarian Cancer AJCC v8; Stage IVB Uterine Corpus Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8

Conditions: Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; Indolent Non-Hodgkin Lymphoma

Conditions: Anaplastic Kidney Wilms Tumor; Recurrent Kidney Wilms Tumor; Stage II Kidney Wilms Tumor; Stage III Kidney Wilms Tumor; Stage IV Kidney Wilms Tumor

Conditions: Soft Tissue Sarcoma

Conditions: Leukemia, Acute Lymphoblastic

Conditions: Triple Negative Breast Cancer

Conditions: Acute Adult T-Cell Leukemia/Lymphoma; Adult T-Cell Leukemia/Lymphoma; Chronic Adult T-Cell Leukemia/Lymphoma; HTLV-1 Infection

Conditions: Early Breast Cancer

Conditions: Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB

Conditions: Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma

Conditions: Triple Negative Breast Cancer

Conditions: Hepatocellular Carcinoma

Conditions: Diffuse Large B Cell Lymphoma

Conditions: Metastatic Breast Cancer

Conditions: Triple-negative Breast Cancer

Conditions: Hematologic Diseases

Conditions: Invasive Breast Cancer

Conditions: Diffuse Large B-cell Lymphoma

Conditions: Aggressive Non-Hodgkin Lymphoma; ALK-Positive Large B-Cell Lymphoma; B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma

Conditions: Hepatocellular Carcinoma

Conditions: Chemotherapy-induced Neutropenia

Conditions: Carcinoma, Non-Small-Cell Lung

Conditions: Soft Tissue Sarcomas

Conditions: High-Risk Neuroblastoma

Conditions: Bladder Urothelial Carcinoma; Stage III Bladder Cancer AJCC v8; Stage IIIA Bladder Cancer AJCC v8; Stage IIIB Bladder Cancer AJCC v8

Conditions: Blastic Plasmacytoid Dendritic Cell Neoplasm

Conditions: Unrecognized Condition

Conditions: Malignant Abdominal Neoplasm; Malignant Pelvic Neoplasm; Recurrent Colon Carcinoma; Recurrent Desmoplastic Small Round Cell Tumor; Recurrent Fallopian Tube Carcinoma; Recurrent Gastric Carcinoma; Recurrent Liposarcoma; Recurrent Malignant Mesothelioma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Recurrent Rectal Carcinoma; Recurrent Rhabdomyosarcoma; Recurrent Sarcoma; Refractory Colon Carcinoma; Refractory Desmoplastic Small Round Cell Tumor; Refractory Fallopian Tube Carcinoma; Refractory Gastric Carcinoma; Refractory Liposarcoma; Refractory Malignant Mesothelioma; Refractory Ovarian Carcinoma; Refractory Primary Peritoneal Carcinoma; Refractory Rectal Carcinoma; Refractory Rhabdomyosarcoma; Refractory Sarcoma; Resectable Liposarcoma; Resectable Malignant Mesothelioma; Resectable Sarcoma

Conditions: Epithelial Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer

Conditions: Advanced Soft Tissue Sarcoma; Advanced Epithelioid Sarcoma

Conditions: Pancreas Cancer

Conditions: Metastatic Sarcoma; Recurrent Sarcoma; Resectable Sarcoma

Conditions: Gastric Neoplasms

Conditions: EBV-Positive DLBCL, Nos